(Q36984808)

English

The impact of individual and methodological factors in the variability of response to methylphenidate in ADHD pharmacogenetic studies from four different continents

scientific article published on December 2008

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

The impact of individual and methodological factors in the variability of response to methylphenidate in ADHD pharmacogenetic studies from four different continents (English)

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

Stephen Faraone

2

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

8

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

Diane Purper-Ouakil

object named as

Diane Purper-Ouakil

13

0 references

Claiton H D Bau

object named as

Claiton H D Bau

3

0 references

object named as

Philip Gorwood

14

0 references

Luis Augusto Rohde

object named as

Luis Augusto Rohde

17

0 references

object named as

Eric Mick

12

0 references

7

object named as

Jan K Buitelaar

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

16

object named as

Edwin H Cook

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

object named as

Keun-Ah Cheon

11

0 references

Guilherme V Polanczyk

1

object named as

Guilherme Polanczyk

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

author name string

Marcelo M Victor

4

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

Katja Becker

5

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

Reta Pelz

6

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

Sandra Kooij

9

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

Emma van der Meulen

10

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

Mark A Stein

15

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

language of work or name

0 references

publication date

1 December 2008

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

American Journal of Medical Genetics Part B: Neuropsychiatric Genetics

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

147B

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

8

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

1419-1424

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

The pharmacogenomic era: promise for personalizing attention deficit hyperactivity disorder therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2587514

29 September 2017

The worldwide prevalence of ADHD: a systematic review and metaregression analysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2587514

29 September 2017

Comparing the efficacy of medications for ADHD using meta-analysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2587514

29 September 2017

Absence of association with DAT1 polymorphism and response to methylphenidate in a sample of adults with ADHD

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2587514

29 September 2017

Attention-deficit/hyperactivity disorder: advancing on pharmacogenomics

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2587514

29 September 2017

Molecular genetics of attention-deficit/hyperactivity disorder

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2587514

29 September 2017

Pharmacogenetics goes genomic

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2587514

29 September 2017

Meta-analysis combining parallel and cross-over clinical trials. I: Continuous outcomes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2587514

29 September 2017

How should meta-regression analyses be undertaken and interpreted?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2587514

29 September 2017

Meta-analyses involving cross-over trials: methodological issues

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2587514

29 September 2017

Statistical heterogeneity in systematic reviews of clinical trials: a critical appraisal of guidelines and practice.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2587514

29 September 2017

ADHD comorbidity findings from the MTA study: comparing comorbid subgroups

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2587514

29 September 2017

Prediction of Clinical Response to Methylphenidate in Children with Attention-Deficit Hyperactivity Disorder

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2587514

29 September 2017

Pharmacogenetics of methylphenidate response in attention deficit/hyperactivity disorder: association with the dopamine transporter gene (SLC6A3).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2587514

4 September 2018

Comorbidity moderates response to methylphenidate in the Preschoolers with Attention-Deficit/Hyperactivity Disorder Treatment Study (PATS).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2587514

4 September 2018

Response to methylphenidate in adults with ADHD is associated with a polymorphism in SLC6A3 (DAT1).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2587514

4 September 2018

Association of dopamine, serotonin, and nicotinic gene polymorphisms with methylphenidate response in ADHD.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2587514

4 September 2018

Differential stimulant response on attention in children with comorbid anxiety and oppositional defiant disorder.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2587514

4 September 2018

Is age-at-onset criterion relevant for the response to methylphenidate in attention-deficit/hyperactivity disorder?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2587514

4 September 2018

The Worldwide Prevalence of ADHD: A Systematic Review and Metaregression Analysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2587514

4 September 2018

Association of the adrenergic alpha2A receptor gene with methylphenidate improvement of inattentive symptoms in children and adolescents with attention-deficit/hyperactivity disorder.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2587514

4 September 2018

High sibling correlation on methylphenidate response but no association with DAT1-10R homozygosity in Dutch sibpairs with ADHD.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2587514

4 September 2018

Dopamine transporter genotype and methylphenidate dose response in children with ADHD.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2587514

4 September 2018

Meta-analysis of the efficacy of methylphenidate for treating adult attention-deficit/hyperactivity disorder

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2587514

4 September 2018

Effects of ethnicity on treatment attendance, stimulant response/dose, and 14-month outcome in ADHD.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2587514

4 September 2018

Report from the 4th international meeting of the attention deficit hyperactivity disorder molecular genetics network

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2587514

4 September 2018

Dopamine transporter gene and response to methylphenidate in attention-deficit/hyperactivity disorder

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2587514

4 September 2018

Developmental aspects of psychostimulant treatment in children and adolescents with attention-deficit/hyperactivity disorder

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2587514

4 September 2018

No significant association between response to methylphenidate and genes of the dopaminergic and serotonergic systems in a sample of Brazilian children with attention-deficit/hyperactivity disorder

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2587514

20 October 2018

Association of 4-repeat allele of the dopamine D4 receptor gene exon III polymorphism and response to methylphenidate treatment in Korean ADHD children

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2587514

20 October 2018

Which boys respond to stimulant medication? A controlled trial of methylphenidate in boys with disruptive behaviour

1 reference

https://pubmed.ncbi.nlm.nih.gov/18802923

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Toward an adequate understanding of attention deficit disorders

1 reference

https://pubmed.ncbi.nlm.nih.gov/18802923

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1002/AJMG.B.30855

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36984808&oldid=1514427772"